Knockdown of astrocyte elevated gene-1 inhibits proliferation and enhancing chemo-sensitivity to cisplatin or doxorubicin in neuroblastoma cells

[1]  Libing Song,et al.  Astrocyte Elevated Gene-1 is a Novel Prognostic Marker for Breast Cancer Progression and Overall Patient Survival , 2008, Clinical Cancer Research.

[2]  Z. Su,et al.  Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling , 2008, Oncogene.

[3]  R. Place,et al.  Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity , 2007, Oncogene.

[4]  P. Fisher,et al.  Astrocyte elevated gene-1 (AEG-1) is a target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc , 2006, Proceedings of the National Academy of Sciences.

[5]  Xianrang Song,et al.  Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1α gene , 2006, Cancer Chemotherapy and Pharmacology.

[6]  P. Fisher,et al.  Activation of the Nuclear Factor κB Pathway by Astrocyte Elevated Gene-1: Implications for Tumor Progression and Metastasis , 2006 .

[7]  P. Fisher,et al.  Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. , 2005, Gene.

[8]  E. Ruoslahti,et al.  Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.

[9]  H. Shimada,et al.  The International Neuroblastoma Pathology Classification. , 2003, Pathologica.

[10]  P. Fisher,et al.  Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH , 2002, Oncogene.

[11]  K K Matthay,et al.  The International Neuroblastoma Pathology Classification (the Shimada system) , 1999, Cancer.

[12]  R. Castleberry.  Predicting outcome in neuroblastoma. , 1999, The New England journal of medicine.

[13]  S. Navarro,et al.  Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting. , 1999, European journal of cancer.

[14]  B. Gallie,et al.  MYCN protein expression as a predictor of neuroblastoma prognosis. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  F. Berthold,et al.  The international neuroblastoma risk groups (INRG): a preliminary report , 1997 .

[16]  P. Fisher,et al.  Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. , 2006, Cancer research.

[17]  A. Craft,et al.  Toxicity of single-day high-dose vincristine, melphalan, etoposide and carboplatin consolidation with autologous bone marrow rescue in advanced neuroblastoma. , 1992, European journal of cancer.